1. Welcome to the All Things Male Forum. Please sign up and join the conversation. It's free!

Testosterone Replacement Therapy And Rehospitalization In Older Men With Testosterone...

Discussion in 'Scientific Studies' started by pubmed: testosterone, Jan 10, 2019.


  1. Testosterone Replacement Therapy and Rehospitalization in Older Men with Testosterone Deficiency in a Post-Acute Care Setting.

    Am J Phys Med Rehabil. 2019 Jan 08;:

    Authors: Al-Lami RA, Graham JE, Deer RR, Westra J, Williams SB, Kuo YF, Baillargeon J

    Abstract
    OBJECTIVE: To examine whether receipt of testosterone replacement therapy (TRT) was associated with reduced 30-day rehospitalization following Post-Acute-Care (PAC) among older men with testosterone deficiency.
    DESIGN, PATIENTS AND METHODS: We conducted a retrospective cohort study using a 5% national sample of Medicare beneficiaries. We identified 1,290 nonsurgical inpatient PAC discharges between January 1, 2007 and October 31, 2014 for male patients, aged ≥66 years, with a prior diagnosis of testosterone deficiency. Multivariable logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for 30-day PAC rehospitalization related to receipt of TRT.
    RESULTS: In older men with testosterone deficiency, receipt of TRT was not associated with rehospitalization (odds ratio [OR]=0.87, 95% CI, 0.59-1.29) in the 30 days following PAC discharge. These findings persisted after adjustment for quintile of propensity scores (OR=0.90, 95%CI=0.62-1.30) CONCLUSION: TRT was not associated with reduced rehospitalization following PAC discharge in older men with testosterone deficiency. Further research in this population should examine the effects of TRT on functional recovery and community independence.

    PMID: 30624240 [PubMed - as supplied by publisher]

    Continue reading...
     

Share This Page

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.